AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax
AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive...

















